Skip to main content
. Author manuscript; available in PMC: 2009 Jul 2.
Published in final edited form as: J Biomol Screen. 2008 May 19;13(5):415–423. doi: 10.1177/1087057108318331

FIG. 7.

FIG. 7

Determination of IC50 for selected inhibitors. Dose response of the inhibition of galactokinase (GALK) activity in the standard pyruvate kinase/lactate dehydrogenase-coupled assay for compounds 1, 3, 9, and 24. Data are shown as a percentage of the corresponding controls (symbols representing mean ± SD) and fitted with a standard log(inhibitor) versus response model (lines) to determine the median inhibitory IC50 values.